Email this article 
Post a Comment 
Hide
Show all
Research Letter
Serum melatonin concentrations in coronary heart disease patients with hypercholesterolaemia
Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie | Vol 20, No 1 | a246 |
DOI: https://doi.org/10.4102/satnt.v20i1.246
| © 2001 Editorial Office
| This work is licensed under CC Attribution 4.0
Submitted: 28 September 2001 | Published: 28 September 2001
Submitted: 28 September 2001 | Published: 28 September 2001
About the author(s)
Editorial Office,, South AfricaFull Text:
PDF (57KB)Share this article
Abstract
This investigation was undertaken to determine the serum melatonin concentrations in coronary heart disease patients (CHD) with hypercholesterolaemia. Hypercholesterolaemia is a contributing factor to atherogenesis in CHD. Melatonin suppresses cholesterol synthesis. The preliminary results indicate that melatonin levels seem to be suppressed in CHD patients with hypercholesterolaemia.
Keywords
No related keywords in the metadata.
Metrics
Total abstract views: 1943Total article views: 1466
Reader Comments
Before posting a comment, read our privacy policy.Post a comment (login required)